So we formed a start-up company to bring this technology to the market and impact people's lives. Now my team and I at ReviveMed are working to discover therapeutics for major diseases that metabolites are key drivers for, like fatty liver disease, because it is caused by accumulation of fats, which are types of metabolites in the liver. As I mentioned earlier, it's a huge epidemic with no treatment.